EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY

EFFECT OF FUROSEMIDE AND TORASEMIDE ON HEART RATE VARIABILITY AND VENTRICULAR RHYTHM DISORDERS IN PATIENTS WITH CHRONIC HEART FAILURE COMPLICATING ISCHEMIC HEART DISEASE: COMPARATIVE NONRANDOMIZED STUDY

Aim. To study effect of diuretic therapy with furosemide and torasemide on heart rate variability (HRV) and frequency of ventriclar rhythm disorders in patients with chronic heart failure (CHF) complicating ischemic heart disease (IHD).Material and methods. Patients (n=107) with CHF III-IV functiona...

Full description

Bibliographic Details
Main Authors:	H. H. Shugushev, A. A. Gaeva
Format:	Article
Language:	English
Published:	Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Series:	Racionalʹnaâ Farmakoterapiâ v Kardiologii
Subjects:	chronic heart failure furosemide torasemide heart rate variability
Online Access:	https://www.rpcardio.com/jour/article/view/853

Similar Items

In dogs with congestive heart failure, is torasemide superior to furosemide as a first line diuretic treatment?
by: Leo Packham
Published: (2020-11-01)

Torasemide – loop diuretic with specific effects
by: V. M. Gorbunov, et al.
Published: (2006-10-01)

Pathogenetic treatment of chronic heart failure: the role of torasemide
by: N B Perepech
Published: (2015-09-01)

Subcutaneous Furosemide in Heart Failure
by: Domenic A. Sica, MD, et al.
Published: (2018-02-01)

TORASEMIDE IN PREVENTION OF MITRAL REGURGITATION AND CHRONIC HEART FAILURE WORSENING IN POSTINFARCTION PERIOD
by: A. A. Abdullaev, et al.
Published: (2018-06-01)

TORASEMIDE SAFETY IN COMPLEX THERAPY OF CHRONIC CARDIAC INSUFFICIENCY: RESULTS OF RANDOMIZED CROSS STUDY
by: E. E. AVERIN
Published: (2016-12-01)

CLINICAL EFFICACY OF LOOP DIURETIC TORASEMIDE IN TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE. RESULTS OF KAZAKHSTAN MULTICENTER STUDY "POET"
by: S. F. Berkinbaev, et al.
Published: (2015-09-01)

Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01)

Torasemid in the treatment of cardiovascular disease: the optimal use in conditions of comorbidity
by: N G Poteshkina, et al.
Published: (2015-12-01)

Use of loop diuretics in heart failure: Current aspects
by: N V Kurlykina, et al.
Published: (2017-09-01)

The potential toxicity of loop diuretics in patients with cardiovascular complications
by: Grzegorz Liczner, et al.
Published: (2018-12-01)

Effects of intravenous furosemide plus small‐volume hypertonic saline solutions on markers of heart failure
by: Antonino Tuttolomondo, et al.
Published: (2021-10-01)

INFLUENCE OF TORASEMIDE ON ELECTRICAL INSTABILITY OF THE HEART IN PATIENTS WITH ISCHEMIC MITRAL REGURGITATION POST MYOCARDIAL INFARCTION
by: I. B. Ibragimova, et al.
Published: (2018-04-01)

Association of early administration of furosemide with improved oxygenation in patients with acute heart failure
by: Takafumi Mikami, et al.
Published: (2021-08-01)

Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
by: N. M. Gafurova, et al.
Published: (2020-09-01)

Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study
by: Alaa Rahhal, et al.
Published: (2019-05-01)

The Nitric Oxide System in Patients with Chronic Heart Failure
by: Dina Arnopolskaya, et al.
Published: (2013-09-01)

Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction
by: Zhigui Zheng, et al.
Published: (2021-06-01)

Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
by: Ayman Ibrahim, et al.
Published: (2020-12-01)

POTASSIUM MONITORING IN HEART FAILURE PATIENTS RECEIVING COMBINED THERAPY OF CAPTOPRIL AND FUROSEMIDE
by: Hubby Hubby, et al.
Published: (2017-08-01)

High doses of torasemide in the doctor’s practice: obvious benefits
by: D.D. Ivanov
Published: (2020-02-01)

Loop diuretics in the treatment of edema: torasemide potentials
by: V V Fomin, et al.
Published: (2008-06-01)

Diuretics in arterial hypertension: a focus on torasemide
by: G A Baryshnikova, et al.
Published: (2012-12-01)

The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches
by: S R Gilyarevsky, et al.
Published: (2014-12-01)

TOXICOLOGICAL AND PHARMACOLOGICAL CHARACTERISTICS OF EXCIPIENTS OF DRUG PRODUCTS OF TORASEMIDE
by: D. Yu. Ivkin, et al.
Published: (2019-01-01)

Diuretic therapy effects on the signal-averaged ECG parameters of atrial complex and supraventricular arrhythmias in patients with coronary heart disease and chronic heart failure
by: Kh. Kh. Shugushev, et al.
Published: (2011-12-01)

The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations
by: Ostroumova O.D., et al.
Published: (2017-09-01)

The efficacy and safety of torasemid in the treatment of arterial hypertension in different clinical situations
by: O D Ostroumova, et al.
Published: (2017-12-01)

Torasemide: additional benefits for postmenopausal women with arterial hypertension
by: O N Tkacheva, et al.
Published: (2013-06-01)

Mechanism of Sodium aescinate combined with Torasemide for cerebral hemorrhage treatment
by: Xiu Yang, et al.
Published: (2017-01-01)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
by: Nappi JM
Published: (2013-03-01)

Effect of edaravone torasemide treatment on elderly patients with acute cerebral hemorrhage
by: Jiao Jiao, et al.
Published: (2016-12-01)

Thermal and photostability studies of furosemide and its cyclodextrin mixtures
by: Melane, Babalwa Blossom
Published: (2002)

Ototoxiska biverkningar av loop-diuretika : Riskfaktorer och skillnader mellan preparaten
by: Lemon, Cassandra
Published: (2016)

Prognostic value of heart rhythm variability in patients with chronic heart failure (three-year investigation)
by: Kosheleva N.A.
Published: (2011-12-01)

Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
by: Fozia Z. Ahmed, et al.
Published: (2021-10-01)

ENDOTHELIAL ADHESIVE FUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE COMPLICATED BY CHRONIC HEART FAILURE AND ATRIAL FIBRILLATION
by: A. N. Zakirova, et al.
Published: (2015-09-01)

Hypertonic saline solution and high-dose furosemide infusion in cardiorenal syndrome: our experience
by: Francesco Ventrella, et al.
Published: (2013-03-01)

Left Ventricular Dysfunction in Ischemic Heart Disease
by: Robert F. Hamburger, DO, MPH, FACC
Published: (2019-01-01)

Management of a patient with dyspnea on an outpatient admission
by: Arkadii L. Vertkin, et al.
Published: (2019-01-01)